Terms: = Prostate cancer AND TPM3, ENSG00000143549, 7170 AND Treatment
4 results:
1. Small molecules targeting the disordered transactivation domain of the androgen receptor induce the formation of collapsed helical states.
Zhu J; Salvatella X; Robustelli P
Nat Commun; 2022 Oct; 13(1):6390. PubMed ID: 36302916
[TBL] [Abstract] [Full Text] [Related]
2. Cyclin-dependent Kinase 4/6 Inhibitor Palbociclib in Combination with Ralaniten Analogs for the treatment of Androgen Receptor-positive prostate and Breast cancers.
Tien AH; Sadar MD
Mol Cancer Ther; 2022 Feb; 21(2):294-309. PubMed ID: 34815359
[TBL] [Abstract] [Full Text] [Related]
3. Combination therapy with androgen receptor N-terminal domain antagonist EPI-7170 and enzalutamide yields synergistic activity in AR-V7-positive prostate cancer.
Hirayama Y; Tam T; Jian K; Andersen RJ; Sadar MD
Mol Oncol; 2020 Oct; 14(10):2455-2470. PubMed ID: 32734688
[TBL] [Abstract] [Full Text] [Related]
4. A New Nomogram Allowing Physicians to Predict Patients at High Risk of Fever Occurring After prostate Biopsy.
Xia H; Wang H; Chen L; Meng J; Zhou J; Liang C
Med Sci Monit; 2020 Mar; 26():e921350. PubMed ID: 32200388
[TBL] [Abstract] [Full Text] [Related]
